Hemodialysis: Acute Complications - Seizure
Does this patient have seizure?
Focal or generalized seizure
Dialysis disequilibrium syndrome
Hard water syndrome (high calcium or magnesium in dialysate)
Cerebrovascular accident (ischemic or hemorrhage)
Malignant hypertension (hypertensive encephalopathy)
Cerebral anoxia due to sustained hypotension
Suboptimal anti-convulsant plasma level (removed during dialysis)
Acute aluminum intoxication
Drug-induced neurotoxicity (theophylline, meperidine, and anti-microbial agents [e.g., penicillin, cefepime, imipenem
What tests to perform?
Laboratory tests should be ordered to identify causes
Blood glucose to exclude hypoglycemia
Serum sodium to exclude hyponatremia
Serum calcium to exclude hypocalcemia or hypercalcemia
Serum magnesium to exclude hypomagnesemia
Neuro-imaging study (CT scan or MRI) should be obtained to exclude intracranial pathology especially in the setting of focal or refractory seizures
Electroencephalography and lumbar puncture may be required
How should patients with seizure be managed?
Maintain airway patency and protection (in case of prolonged postictal state)
Intravenous benzodiazepine such as lorazepam (first choice), diazepam, and midazolam
Intravenous phenytoin if uncontrolled by benzodiazepine
Intravenous 50% dextrose in water if hypoglycemia is suspected
Identify causes and correct causes
What happens to patients with seizure?
Need for hospitalization
Risk of aspiration pneumonitis
Risk of permanent neurological damage (especially in status epilepticus)
How to utilize team care?
1. Specialty consultations – Neurologist
2. Nursing - Close monitoring of high-risk patients with frequent neurological assessment
Are there clinical practice guidelines to inform decision making?
2013 updated evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes (Published by The International League Against Epilepsy, ILAE)
Limitations: Focused on long-term efficacy as initial monotherapy for patients with newly diagnosed or untreated epilepsy (not dialysis patients).
ICD-10-CM diagnosis code R56.9: Unspecified convulsion
What is the evidence?
Glauser, T, Ben-Menachem, E, Bourgeois, B, Cnaan, A, Guerreiro, C, Kälviäinen, R, Mattson, R, French, JA, Perucca, E, Tomson, T. "ILAE Subcommission on AED Guidelines. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes". Epilepsia. vol. 54. 2013. pp. 551-63.
Copyright © 2017, 2013 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Sign Up for Free e-newsletters
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- When There Are No Words: Interpreting Patients' and Families' Subtle Messages
- Depression Predictive of Poor Survival Outcomes in Head and Neck Cancer
- Nearly One Third of Veterans Report Current Tobacco Use
- Priority Review of New Drug Application Granted to Apalutamide for CRPC
- Partial Response Achieved With Atezolizumab, Cobimetinib in Pretreated CRC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|